Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Employees Gencure Rogelio Zamilpa

Rogelio Zamilpa

Highest compensated employee

Executive Director, Biomanufacturing and Collab at Gencure

Fiscal year ended December 31, 2024. Published on January 25, 2026.

$242,621
2024

Total compensation

Rogelio Zamilpa has been listed as an employee of Gencure in Form 990 filings since fiscal year 2018. Total compensation for Rogelio Zamilpa has increased by 44.7% from 2018 to 2024.

Annual compensation details

$242,621
+0.6%
Executive Director, Biomanufacturing and Collab
2024
$216k
50 hrs/wk
$28k
--
$241,163
+10.2%
SR Director, MFG Sciences and Technology
2023
$210k
50 hrs/wk
$32k
--
$218,893
+7.2%
SR Director, MFG Sciences
2022
$191k
50 hrs/wk
$29k
--
$204,241
+0.2%
SR Director, MFG Sciences
2021
$177k
50 hrs/wk
$28k
--
$203,912
+9.5%
Director, OPS, Gencure Biomanu
2020
$177k
50 hrs/wk
$28k
--
$186,230
+11%
Executive Director Apheresis A
2019
$159k
50 hrs/wk
$28k
--
$167,709
Director Apheresis and CORD BLOO
2018
$143k
50 hrs/wk
$26k
--

Total compensation by year

Compare the compensation of Rogelio Zamilpa to:

Revisions to this profile

January 25, 2026:
2024 Gencure 990 published
January 25, 2026:
2023 Gencure 990 published
January 25, 2026:
2022 Gencure 990 published

Get an email update when compensation for Rogelio Zamilpa is updated

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →
2024

Other employees at Gencure

Geoffrey Kindt
General Manager, Biomanufacturing (Thru 11/02/2024)
$374,356
$260,606 $28,837 $84,913
Mari Lane Salmi
SR Director, Process DEV and CELL Therapies
$244,354
$203,361 No related comp$40,993
Milton Masayuki Pollard
Vice President, Gencure Operations (Thru 07/09/2024)
$219,747
$196,274 No related comp$23,473
Amanda Whitelonis
Principal Global Market Development (Effective 11/03/2024)
$219,270
$20,119 $171,875 $27,276
Miguel Garza
Director, Operations Biomanufacturing
$176,156
$156,301 No related comp$19,855